San Raffaele
San Raffaele
Italy, Milan
Andres Jose Maria Ferreri
28 years of experience
accreditations :
Clinic is certified :
Chemotherapy for lung cancer in Italy typically costs from $3,100 to $6,200. Final expenses depend on the drug regimen, cycle frequency, and clinic tier. In the US, similar treatments cost around $104,000 on average. Patients can find significant savings in Italy, often around 95%. Standard costs usually cover drug administration and necessary specialist consultations.
Bookimed Expert Insight: Choosing a research-heavy facility like San Raffaele in Milan offers exceptional value. This hospital combines clinical care with intense research activity. Treatment there typically runs about $15,500 to $26,600. It is ranked among the World's Best Hospitals by Newsweek. Patients benefit from IRCCS accreditation and access to cutting-edge protocols. This provides high-tier medicine at competitive private rates.
Why choose Italy for chemotherapy for lung cancer?
Access advanced Chemotherapy for lung cancer solutions in trusted clinics .
| Italy | Turkey | Austria | |
| Chemotherapy for lung cancer | from $3,100 | from $1,000 | from $19,200 |
No hidden fees – just official clinic prices. Pay at the clinic for Chemotherapy for lung cancer upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Chemotherapy for lung cancer and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Chemotherapy for lung cancer journey.
Day 1
Day 2
Day 3 - Treatment Day
Day 4 - Post-Treatment
Week 1-2
Week 3-4 - Rehabilitation
Please note that the timeline and process might vary based on individual patient"s condition and response to treatment.
The doctor serves as the Deputy Director of the Hematology Oncology Department and Director of the Lymphoma Unit at the San Raffaele Scientific Institute, with a focus on lymphoma treatment.
He is the founder of the Italian Lymphoma Foundation, dedicated to advancing clinical studies in lymphoma management.
His academic background includes a degree in general medicine and surgery from the University of Buenos Aires and the University of Parma, and a specialty in medical oncology from the University of Milan.
The doctor has authored over 300 papers on lymphoma treatment and is a member of several prestigious hematology and oncology societies.
Chemo uses cancer drugs to kill or stop the growth of cancer cells in the lungs.